Intellia Therapeutics Inc - NTLA - stock price prediction, stock price target, analyst ratings from 26 analysts

Intellia Therapeutics Inc has a share price target of US$ 34, revenue growth forecast of 7.9%, and profit growth estimate of 16.8% for FY25, based on top 26 analyst calls.